Regulation of Macrophage Recognition through the Interplay of Nanoparticle Surface Functionality and Protein Corona.
暂无分享,去创建一个
Sung Tae Kim | Vincent M. Rotello | Morteza Mahmoudi | Mahdieh Yazdani | Farhad Rezaee | Krishnendu Saha | S. Hou | V. Rotello | M. Mahmoudi | R. Mout | Krishnendu Saha | Sung Tae Kim | Mahdieh Yazdani | Daniel F. Moyano | Riddha Das | F. Rezaee | Daniel Moyano | Rubul Mout | Mehran Rahimi | Mehran Rahimi | Singyuk Hou | Riddha Das | Ridhha Das
[1] V. Rotello,et al. Beauty is skin deep: a surface monolayer perspective on nanoparticle interactions with cells and bio-macromolecules. , 2011, Small.
[2] Robert Langer,et al. Degradable Lipid Nanoparticles with Predictable In Vivo siRNA Delivery Activity , 2014, Nature Communications.
[3] Farhad Rezaee,et al. Proteomic analysis of high‐density lipoprotein , 2006, Proteomics.
[4] Denis Hochstrasser,et al. How shall we use the proteomics toolbox for biomarker discovery? , 2007, Journal of proteome research.
[5] K. Hamad-Schifferli,et al. Protein coronas on gold nanorods passivated with amphiphilic ligands affect cytotoxicity and cellular response to penicillin/streptomycin. , 2014, ACS nano.
[6] Elodie Boisselier,et al. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. , 2009, Chemical Society reviews.
[7] Nicholas A Peppas,et al. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.
[8] V. Puntes,et al. Inorganic nanoparticle biomolecular corona: formation, evolution and biological impact. , 2012, Nanomedicine.
[9] Iseult Lynch,et al. What the cell "sees" in bionanoscience. , 2010, Journal of the American Chemical Society.
[10] Andrew Emili,et al. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. , 2012, Journal of the American Chemical Society.
[11] Vincent M Rotello,et al. Intracellular delivery of a membrane-impermeable enzyme in active form using functionalized gold nanoparticles. , 2010, Journal of the American Chemical Society.
[12] M. Mahmoudi,et al. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. , 2011, Advanced drug delivery reviews.
[13] Christopher J. Kiely,et al. Synthesis and reactions of functionalised gold nanoparticles , 1995 .
[14] A. Blom,et al. Vitamin K-Dependent Protein S Localizing Complement Regulator C4b-Binding Protein to the Surface of Apoptotic Cells1 , 2002, The Journal of Immunology.
[15] V. Rotello,et al. Electrostatic selectivity in protein-nanoparticle interactions. , 2011, Biomacromolecules.
[16] James Chen Yong Kah,et al. Optimizing the properties of the protein corona surrounding nanoparticles for tuning payload release. , 2013, ACS nano.
[17] V. Rotello,et al. Probing the protein–nanoparticle interface: the role of aromatic substitution pattern on affinity , 2015, Supramolecular chemistry.
[18] K. Hamad-Schifferli. Exploiting the novel properties of protein coronas: emerging applications in nanomedicine. , 2015, Nanomedicine.
[19] A. Blom,et al. Surface of Apoptotic Cells Complement Regulator C 4 b-Binding Protein Vitamin K-Dependent Protein S Localizing , 2002 .
[20] Iseult Lynch,et al. Protein-nanoparticle interactions: What does the cell see? , 2009, Nature nanotechnology.
[21] M. Mahmoudi,et al. Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake. , 2016, Biomaterials.
[22] Andrew Emili,et al. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. , 2014, ACS nano.
[23] Eric Pridgen,et al. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.
[24] Pablo Del Pino,et al. Interfacing engineered nanoparticles with biological systems: anticipating adverse nano-bio interactions. , 2013, Small.
[25] Daniel G. Anderson,et al. Non-viral vectors for gene-based therapy , 2014, Nature Reviews Genetics.
[26] Eric R. Ziegel,et al. Statistics and Chemometrics for Analytical Chemistry , 2004, Technometrics.
[27] Vincent M Rotello,et al. Detection and identification of proteins using nanoparticle-fluorescent polymer 'chemical nose' sensors. , 2007, Nature nanotechnology.
[28] V. Rotello,et al. Size and geometry dependent protein-nanoparticle self-assembly. , 2009, Chemical communications.
[29] Alexander Kabanov,et al. Facilitated Monocyte-Macrophage Uptake and Tissue Distribution of Superparmagnetic Iron-Oxide Nanoparticles , 2009, PloS one.
[30] V. Rotello,et al. Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles , 2011, PloS one.
[31] Iseult Lynch,et al. Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery". , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[32] Morteza Mahmoudi,et al. Protein Corona Composition of Superparamagnetic Iron Oxide Nanoparticles with Various Physico-Chemical Properties and Coatings , 2014, Scientific Reports.
[33] Marco P Monopoli,et al. Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.
[34] Warren C W Chan,et al. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. , 2012, Chemical Society reviews.
[35] Vincent M Rotello,et al. Efficient gene delivery vectors by tuning the surface charge density of amino acid-functionalized gold nanoparticles. , 2008, ACS nano.
[36] James Chen Yong Kah,et al. Exploiting the protein corona around gold nanorods for loading and triggered release. , 2012, ACS nano.
[37] Andrzej S Pitek,et al. Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. , 2012, ACS nano.
[38] M. Peppelenbosch,et al. Proteome of human plasma very low-density lipoprotein and low-density lipoprotein exhibits a link with coagulation and lipid metabolism , 2014, Thrombosis and Haemostasis.
[39] Stefan Tenzer,et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. , 2013, Nature nanotechnology.
[40] V. Rotello,et al. Protein coronas suppress the hemolytic activity of hydrophilic and hydrophobic nanoparticles. , 2014, Materials horizons.
[41] Tamara Posati,et al. The interplay of monolayer structure and serum protein interactions on the cellular uptake of gold nanoparticles. , 2012, Small.
[42] Vincent M Rotello,et al. Nano meets biology: structure and function at the nanoparticle interface. , 2011, Langmuir : the ACS journal of surfaces and colloids.
[43] Raimo Hartmann,et al. Temperature: the "ignored" factor at the NanoBio interface. , 2013, ACS nano.
[44] M. Mahmoudi,et al. Protein-nanoparticle interactions: opportunities and challenges. , 2011, Chemical reviews.
[45] Cui Tang,et al. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. , 2010, Biomaterials.
[46] Iseult Lynch,et al. Formation and characterization of the nanoparticle-protein corona. , 2013, Methods in molecular biology.
[47] E. Sijbrands,et al. Characterization of coagulation factor synthesis in nine human primary cell types , 2012, Scientific Reports.
[48] Kenneth A. Dawson,et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.
[49] Parag Aggarwal,et al. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[50] Sung Tae Kim,et al. Gold nanoparticles for nucleic acid delivery. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.
[51] Dan Peer,et al. Nanoparticle hydrophobicity dictates immune response. , 2012, Journal of the American Chemical Society.
[52] F. Mooi,et al. Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin , 1997, Infection and immunity.
[53] M. Mahmoudi,et al. Plasma concentration gradient influences the protein corona decoration on nanoparticles , 2013 .
[54] Ho Sup Yoon,et al. Co-delivery of drugs and DNA from cationic core–shell nanoparticles self-assembled from a biodegradable copolymer , 2006, Nature materials.
[55] V. Rotello,et al. Preparation of 2 nm gold nanoparticles for in vitro and in vivo applications. , 2013, Methods in molecular biology.
[56] Iseult Lynch,et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.
[57] E. Johnsson,et al. A highly variable region in members of the streptococcal M protein family binds the human complement regulator C4BP. , 1996, Journal of Immunology.
[58] J. Vallée,et al. Ex situ evaluation of the composition of protein corona of intravenously injected superparamagnetic nanoparticles in rats. , 2014, Nanoscale.
[59] A. Blom,et al. C4b-binding Protein and Factor H Compensate for the Loss of Membrane-bound Complement Inhibitors to Protect Apoptotic Cells against Excessive Complement Attack* , 2007, Journal of Biological Chemistry.
[60] Marc D. Porter,et al. Alkanethiolate Gold Cluster Molecules with Core Diameters from 1.5 to 5.2 nm: Core and Monolayer Properties as a Function of Core Size , 1998 .
[61] Bruno F B Silva,et al. Uptake and transfection efficiency of PEGylated cationic liposome-DNA complexes with and without RGD-tagging. , 2014, Biomaterials.
[62] G. Lindahl,et al. Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system. , 1995, Journal of immunology.